Biltmore Family Office’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$617K Buy
1,520
+1
+0.1% +$406 0.1% 114
2025
Q1
$757K Hold
1,519
0.13% 100
2024
Q4
$791K Hold
1,519
0.13% 96
2024
Q3
$940K Sell
1,519
-13
-0.8% -$8.05K 0.16% 88
2024
Q2
$848K Buy
1,532
+5
+0.3% +$2.77K 0.16% 86
2024
Q1
$888K Buy
1,527
+53
+4% +$30.8K 0.18% 84
2023
Q4
$783K Buy
1,474
+27
+2% +$14.3K 0.16% 88
2023
Q3
$733K Hold
1,447
0.17% 84
2023
Q2
$755K Sell
1,447
-1,144
-44% -$597K 0.16% 86
2023
Q1
$1.49M Sell
2,591
-1
-0% -$577 0.32% 53
2022
Q4
$1.43M Buy
2,592
+1,144
+79% +$630K 0.29% 51
2022
Q3
$735K Buy
1,448
+1
+0.1% +$508 0.17% 78
2022
Q2
$787K Hold
1,447
0.2% 81
2022
Q1
$855K Sell
1,447
-798
-36% -$472K 0.18% 83
2021
Q4
$1.5M Hold
2,245
0.29% 57
2021
Q3
$1.28M Buy
2,245
+796
+55% +$455K 0.31% 55
2021
Q2
$731K Buy
1,449
+44
+3% +$22.2K 0.21% 80
2021
Q1
$642K Hold
1,405
0.2% 76
2020
Q4
$655K Hold
1,405
0.2% 73
2020
Q3
$621K Hold
1,405
0.35% 65
2020
Q2
$509K Hold
1,405
0.31% 79
2020
Q1
$399K Hold
1,405
0.26% 92
2019
Q4
$457K Buy
1,405
+22
+2% +$7.16K 0.18% 101
2019
Q3
$403K Buy
1,383
+11
+0.8% +$3.21K 0.17% 110
2019
Q2
$403K Hold
1,372
0.22% 95
2019
Q1
$376K Hold
1,372
0.19% 107
2018
Q4
$307K Hold
1,372
0.17% 114
2018
Q3
$335K Hold
1,372
0.16% 114
2018
Q2
$284K Hold
1,372
0.14% 119
2018
Q1
$283K Hold
1,372
0.13% 133
2017
Q4
$261K Buy
+1,372
New +$261K 0.12% 136